Influence of high-density lipoprotein cholesterol and rheological factors on the sex difference in cardiovascular disease

European Journal of Preventive Cardiology

Volumn 7, Issue 1, 2000, Pages 49-56

  Price, Jacqueline F ^a   Lee, Amanda J ^a   Fowkes, F Gerald R ^a   Housley, Edward ^a   Riemersma, Rudolph A ^a,b   Lowe, Gordon D O ^c  

^a Public Health Sciences

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

blood viscosity; cardiovascular disease; lipoproteins; plasma viscosity; sex

Indexed keywords

HIGH DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; BLOOD RHEOLOGY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; DISEASE ASSOCIATION; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE;

AGE DISTRIBUTION; AGED; BLOOD VISCOSITY; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; COHORT STUDIES; CONFIDENCE INTERVALS; DISEASE SUSCEPTIBILITY; FEMALE; GREAT BRITAIN; HEMODYNAMIC PROCESSES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 84992920669     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/204748730000700109     Document Type: Article

References (32)

1. Kalin MF, Zumoff B. Sex hormones and coronary disease: A review of the clinical studies. Steroids 1990; 55: 330–352.
2. Brezinka V, Padmos I. Coronary heart disease risk factors in women. Eur Heart J 1994; 15: 1571–1584.
3. Johnson A. Sex differentials in coronary heart disease: the explanatory role of primary risk factors. J Health Soc Behav 1977; 18: 46–54.
4. Janghorbani M, Hedley AJ, Jones RB, Zhianpour M, Gilmour WH. Gender differential in all-cause and cardiovascular disease mortality. Int J Epidemiol 1993; 22: 1056–1063.
5. Wingard DL. The sex differential in mortality rates: demographic and behavioural factors. Am J Epidemiol 1982; 115: 205–216.
6. Wingard DL, Suarez L, Barrett-Connor E. The sex differential in mortality from all causes and ischaemic heart disease. Am J Epidemiol 1983; 117: 165–172.
7. Larsson B, Bengtsson C, Björntorp P, Lapidus L, Sjöström L, Svärdsudd K, et al. Is abdominal fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? Am J Epidemiol 1992; 135: 266–273.
8. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspectives from the Framingham Study. Am Heart J 1987; 114: 413–419.
9. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: 26 year follow-up of the Framingham Study. Am Heart J 1986; 111: 383–390.
10. Gordon DJ, Probstfield JL, Garrison RJ. High density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989; 79: 8–15.
11. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. Arch Intern Med 1993; 153: 598–615.
12. Manolio TA, Pearson TA, Wenger NK, Barrett-Conor E, Payne GH, Harlan WR. Cholesterol and heart disease in older persons and women: review of an NHLBI workshop. Ann Epidemiol 1992; 2: 161–176.
13. Fowkes FGR, Pell JP, Donnan PT, Housley E, Lowe GDO, Riemersma RA, et al. Sex differences in susceptibility to etiologic factors for peripheral atherosclerosis. Importance of plasma fibrinogen and blood viscosity. Arterioscl Thromb 1994; 14: 862–868.
14. Yarnell JWG, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation 1991; 83: 836–844.
15. Koenig W, Ernst E. The possible role of haemorheology in atherothrombogenesis. Atherosclerosis 1992; 94: 93–107.
16. Lowe GDO, Lee AJ, Rumley, Price J.F., Fowkes FGR. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol 1997; 96: 168–173.
17. Fowkes FGR, Housley E, Cawood EHH, MacIntyre CCA, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20: 384–391.
18. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull WHO 1962; 27: 645–658.
19. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code manual of electro-cardiographic findings: standards and procedures for measurement and classification. London: John Wright; 1982.
20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
21. Lowe GDO, Fowkes FGR, Dawes J, Donnan PT, Lennie SE, Housley E. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 1993; 87: 1915–1920.
22. Lowe GDO, Smith WCS, Tunstall-Pedoe HD, Crombie I, Anderson J, Barbenel JC. Cardiovascular risk and haemorheology. Results from the Scottish Heart Health Study and the MONICA Project, Glasgow. Clin Hemorheol 1988; 8: 517–524.
23. Gillum RF, Fortmann SP, Prineas RJ, Kottke TE. Internatiqnal diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J 1984; 108: 150–158.
24. Leng GC, Lee AJ, Fowkes FGR, Whiteman M, Dunbar J, Housley E, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996; 25: 1172–1181.
25. Zhang XH, Sasaki S, Kesteloot H. The sex ratio of mortality and its secular trends. Int J Epidemiol 1995; 24: 720–729.
26. Breeze E, Maidment A, Bennett N, Flatley J, Carey S. Health survey for England 1992. A survey carried out by the Social Survey Division of OPCS on behalf of the Department of Health. London: HMSO; 1994.
27. Meade TW, North WRS, Chakrabarti RR, Haines AP, Stirling Y. Population-based distributions of haemostatic variables. BMJ 1977; 33: 283–288.
28. Kesteloot H, Sasaki S. On the relationship between nutrition, sex hormones and high-density lipoproteins in women. Acta Cardiol 1993; 48: 355–363.
29. Kesteloot H, Huang DX, Yang XS, Claes J, Rosseneu M, Geboers J, er al. Serum lipids in the People's Republic of China. Comparison of western and eastern populations. Arteriosclerosis 1985; 5: 427–433.
30. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease: the Framingham Study. JAMA 1987; 258: 1183–1186.
31. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of haemostatic factors and incidence of coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997; 96: 1102–1108.
32. Woodward M, Lowe GDO, Rumley A, Tunstall-Pedoe H. Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women. The Scottish Heart Health Study. Eur Heart J 1998; 19: 55–62.